Ashibio Inc
Ashibio Inc
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) | Foot Deformities, Hallux Valgus, Inflammation, Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 / Phase 3 | 2025-10-14 | NCT06508021 | |
| A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. | Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 1 / Phase 2 | 2025-06-17 | NCT07024407 |